Could a common diabetes pill protect heart attack survivors?
NCT ID NCT05050500
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study tested whether dapagliflozin, a diabetes drug, can help people with type 2 diabetes recover better after a heart attack. Researchers measured inflammation levels and tracked heart-related events like another heart attack or stroke. The goal was to see if the drug improves short-term outcomes compared to a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mengmei Li
Qingdao, Shandong, 266042, China
Conditions
Explore the condition pages connected to this study.